{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:40:05Z","timestamp":1761561605028,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":471,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.amjcard.2011.11.033","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T10:17:15Z","timestamp":1325672235000},"page":"1015-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Follow-Up with Exercise Test of Effort-Induced Ventricular Arrhythmias Linked to Ryanodine Receptor Type 2 Gene Mutations"],"prefix":"10.1016","volume":"109","author":[{"given":"Alexandros Klavdios","family":"Steriotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Rampazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Thiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Daliento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Franco","family":"Folino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Rigato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Beffagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Carturan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bauce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2011.11.033_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.yjmcc.2009.06.014","article-title":"Regulation of basal and reserve cardiac pacemaker function by interactions of cAMP-mediated PKA-dependent Ca2+ cycling with surface membrane channels","volume":"47","author":"Vinogradova","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2009.03.006","article-title":"Ryanodine receptor-mediated arrhythmias and sudden cardiac death","volume":"123","author":"Blayney","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2011.11.033_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cpcardiol.2008.09.002","article-title":"Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond","volume":"34","author":"Katz","year":"2009","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib4","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1073\/pnas.0402388101","article-title":"RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjcard.2011.11.033_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.110.227744","article-title":"In the RyR2(R4496C) mouse model of CPVT, \u03b2-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves","volume":"107","author":"Kashimura","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2011.11.033_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/eurheartj\/ehl543","article-title":"Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves","volume":"28","author":"Paavola","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2011.11.033_bib7","doi-asserted-by":"crossref","first-page":"H2144","DOI":"10.1152\/ajpheart.00924.2006","article-title":"Ryanodine receptor dysfunction and triggered activity in the heart","volume":"292","author":"Katra","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCRESAHA.107.148064","article-title":"Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia","volume":"101","author":"Cerrone","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2011.11.033_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/hmg\/10.3.189","article-title":"Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)","volume":"10","author":"Tiso","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.amjcard.2011.11.033_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","article-title":"Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia","volume":"103","author":"Laitinen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.033_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.033_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.humpath.2005.04.019","article-title":"Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates","volume":"36","author":"D'Amati","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib13","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib14","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4065\/79.11.1380","article-title":"Targeted mutational analysis of the RYR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner\/coroner's cases","volume":"79","author":"Tester","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2011.11.033_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2009.08.041","article-title":"Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro","volume":"147","author":"Marjamaa","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.carpath.2010.02.003","article-title":"Sudden cardiac death with normal heart: molecular autopsy","volume":"19","author":"Basso","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0735-1097(02)01946-0","article-title":"Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers","volume":"40","author":"Bauce","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.amjcard.2011.11.033_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pcad.2007.10.005","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"51","author":"Liu","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2011.11.033_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.033_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5273(88)90212-4","article-title":"Juvenile sudden death and effort ventricular tachycardias in a family with right ventricular cardiomyopathy","volume":"21","author":"Nava","year":"1988","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib22","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.hrthm.2008.08.038","article-title":"Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome","volume":"5","author":"Horner","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2011.11.033_bib23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1373\/clinchem.2003.030734","article-title":"Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias","volume":"50","author":"Bagattin","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.amjcard.2011.11.033_bib24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task Force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.033_bib25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2011.11.033_bib26","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.11.033_bib27","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2011.11.033_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.amjcard.2011.11.033_bib29","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"Van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.11.033_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/europace\/eup448","article-title":"High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening","volume":"12","author":"Haugaa","year":"2010","journal-title":"Europace"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911034497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911034497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:23:22Z","timestamp":1757571802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914911034497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0002914911034497"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2011.11.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follow-Up with Exercise Test of Effort-Induced Ventricular Arrhythmias Linked to Ryanodine Receptor Type 2 Gene Mutations","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2011.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}